1Bonadonna G,Valagussa P,Tancini G,et al.Current status ofMilan adjuvant chemotherapy trials for node-positive and node-negative breast cancer[J].NCI Monogr,1986,(1):45-49.
2Fisher B,Redmond C,Fisher ER,et al.Systemic adjuvanttherapy in treatment of primary operable breast cancer:NationalSurgical Adjuvant Breast and Bowel Project experience[J].NCIMonogr,1986,(1):35-43.
3Bull J,Tormey D,Li SH,et al.A randomized comparative trial ofAdriamycin versus methotrexate in combination drug therapy[J].Cancer,1978,41(5):1649-1657.
4Herait P, Poutignat N, Marty M, et al.Early assessment of a new anticancer drug analogue are the historical comparisons obsolete? The French Experience with pirarubicin[J]. Eur J Cancer, 1992,28A:1670.
5Brincker H. Distant recurrence in breast cancer. Survival expectations and first choice of chemotherapy regimen[J]. Acta Oncol,1988,27(6A) :729-732.
6Tominage T. A randomized controlled study of ( 2''R )-4'-O-tetrahydropy-ranyladriamycin and adriamycin in combination with cyclophosphamide and 5-fluorouracil in the treatment of advanced and recurrent breast cancer.Clinical Study Group of THP for Breast Cancer in Japan [J]. Biomed-pharmacother, 1989,43 (4):271 - 278.
7Tatuo S,Yoichi K,Akira W,et al. Multi-insitutional cooperative study. Phase Ⅱ study of (2''rR)-4-O-tetrahy dropyrany-ladriamycin (THP) in patients with solid tumors [J]. Jpn J Cancer Chemother, 1986,13 (4) : 1060.
8Pierga JY, Mouret E, Dieras V, et al. Prognostic value of persistent node involvement after neoadjuvant chemotherapy in patients with operable breast cancer[J]. BrJ Cancer, 2000, 83(11): 1480～1487.
9Chollet P, Charrier S, Brain E, et al. Clinical and pathological response to primary chemotherapy in operable breast cancer[J].EurJ Cancer, 1997, 33(6): 862～866.
10Fisher B, Bryant J, Wolmark N, et al. Effect of pre-operative chemotherapy on the outcome of women with operable breast cancer[J].J Clin Oncol, 1998, 16(8): 2672～2685.
2Jones EL, Leak A, Muss HB. Adjuvant therapy of breast cancer in women 70 years of age and older: tough decisions, high stakes [J]. Oncology (Williston Park), 2012, 26:793-801.
3冯长顺.钼靶X线摄影在乳腺癌诊断中的应用[J].中外健康文摘,2012,9:218-218.
4邹玉芳.乳腺癌的检查及治疗进展[J].中外健康文摘,2012,9:133-133.
5Paesmans M, Ameye L, Moreau M, et al. Breast cancer screen- ing in the older woman: an effective way to reduce mortality[J]. Maturitas, 2010, 66 : 263-267.
6Cutuli B, De Lafontan B, Vitali E, et al. Breast conserving treatment (BCT) for stage I-II breast cancer in elderly women: analysis of 927 cases[ J]. Crit Rev Oncol Hematol, 2009, 71: 79-88.
